4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020997
Chief Scientific Officer sold 2,899 shares at an average $0.61 ($1,779)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loose Christopher R. Chief Scientific Officer | 2023-07-17 | Sale 10b5-1 | −1,415 | $0.67 | $948 | 196,037 | D: show line 1 in the form |
| Loose Christopher R. Chief Scientific Officer | 2023-07-18 | Sale 10b5-1 | −1,484 | $0.56 | $831 | 194,553 | D: show line 2 in the form |
| Open-market sales · 2,899 sh · avg $0.61 · $1,779 | |||||||
Loading xslF345X05/form4.xml…